Columbia University Irving Medical Center/NY Presbyterian Hospital — New York, New York

Columbia University Irving Medical Center/NY Presbyterian Hospital is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

Columbia University Irving Medical Center/NY Presbyterian Hospital has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Aortic Aneurysm, Abdominal, Juxtarenal Aortic Aneurysm, Extent IV Thoracoabdominal.

Sponsors: Cook Research Incorporated, Boston Scientific Corporation.

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Columbia University Irving Medical Center/NY Presbyterian Hospital?

Columbia University Irving Medical Center/NY Presbyterian Hospital has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Columbia University Irving Medical Center/NY Presbyterian Hospital conducted?

Columbia University Irving Medical Center/NY Presbyterian Hospital has 2 clinical trials on record, with 1 currently active. Their work covers Aortic Aneurysm, Abdominal, Juxtarenal Aortic Aneurysm, Extent IV Thoracoabdominal.

Is Columbia University Irving Medical Center/NY Presbyterian Hospital accredited by Crixeo Health?

Columbia University Irving Medical Center/NY Presbyterian Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Columbia University Irving Medical Center/NY Presbyterian Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.